stocksbrew
Market
Explore
Watchlist
Market
Explore
Watchlist
stocksbrew.

Analyse any US stock, then track the ones you care about.

Appearance

Product

  • Market today
  • Explore
  • Watchlist
  • Earnings
  • US stocks
  • AI agent access

Free tools

  • Should I Buy?
  • Compare stocks
  • Portfolio Analyzer
  • Market Heat
  • Screens

Resources

  • Learn & guides
  • Blog
  • Use cases
  • Developer API

Company

  • About
  • Pricing
  • Contact
  • Terms of service
  • Privacy policy

© 2026 stocksbrew. All rights reserved.

stocksbrew provides market data and analytics for informational purposes only. Nothing here is investment advice. Past performance does not guarantee future results.

stocksbrew — Verified on SubmitForBacklinksFeatured on ScrollLaunchLaunched on FazierStocksBrew - Featured on Startup FameFeatured on Wired Business
EN
ENSG stock logo

Ensign Group

Large Cap · Healthcare · Medical Care Facilities

$183.98+$1.49 (+0.82%)
EN
ENSG stock logo

Ensign Group

Large Cap · Healthcare · Medical Care Facilities

$183.98+$1.49 (+0.82%)

Stock analysis

$183.98+$1.49 (+0.82%)

Get the AI take on ENSG

Track it to unlock the price chart, verdict and what could change it.

  • ✓Live price chart
  • ✓A clear accumulate, trim or avoid call

Free to track. No card required.

Stock Fundamentals & Key Indicators

52-week range
Low$134.79
High$218.00
Today $183.98
RSI (14)
73.7Overbought
03070100

Overall score

66/100

See the full financial picture

Open the five-year record, valuation checks and Wall Street view behind these scores.

  • ✓5 years of revenue, profit and cash flow
  • ✓Valuation and balance-sheet checks
  • ✓Business and geographic mix
  • ✓Analyst targets and recommendation trend

Free for 3 days, then $9/mo. Cancel anytime.

Analyst Rating and Sentiment

Analyst price targets

Current price

$183.98

Lowest

$207

Median target

$225

Highest

$230

LowHigh

Operating Record

Revenue

What's working

  • Price / sales: You're paying a modest amount for each dollar of revenue coming in.
  • ROE: Shareholder capital is compounding at a rate worth paying attention to.

What to watch

  • Debt exceeds cash by $1.9B, increasing balance-sheet pressure, a warning sign.

What the market charges

Forward P/E

Middle ground · 6% above avg

22.12x

Price / sales

Strong · Priced modestly against the revenue it brings in

1.91x

Price / FCF

Reasonable · Priced a bit rich against its cash flow

25.05x

EV / EBITDA

Reasonable · Operating earnings make this price a stretch but plausible

21.33x

How efficiently it compounds

ROIC

Reasonable · A middling return on the capital it puts to work

8.5%

ROE

Favorable · 16.9% - solid capital efficiency

17.0%

Debt / equity

Middle ground · Mixed

0.92x

Current ratio

Reasonable · Just enough on hand to cover near-term bills

1.21x

Peer Comparison

CompanyMkt capP/ERev growthScore
EN
ENSG stock logo
ENSGEnsign Group
$10.59B28.5+18.9%66
GM
GMED stock logo
GMEDGlobus Medical
$11.53B22.0+19.7%78
IN
INDV stock logo
INDVIndivior
$4.60B13.9+13.5%77
DX
DXCM stock logo
DXCMDexcom
$33.87B35.4+15.5%77
LL
LLY stock logo
LLYEli Lilly and Company
$1.11T40.1+49.6%76